Since both miR-1291 and CPT1C were identified as tumor biomarkers in pancreatic cancer 1,2,11 and both are closely related to tumor metabolism 4,5,12, the assumption was made that they may be mechanistically linked in their impact on cancer. This evidence concerns the gene CPT1C and pancreatic neoplasm.